Skip to content

Laryngeal Masks for Bariatric Surgery

A Randomized Comparative Study on Proseal LMATM and Supreme LMATM for Bariatric Surgery.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01724970
Enrollment
80
Registered
2012-11-12
Start date
2012-07-31
Completion date
2014-07-31
Last updated
2012-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

anesthesia, postanesthetic recovery, ventilation, bariatric surgery

Brief summary

Obese people pose specific problems as far as the management of airway during surgery. The study aims to compare efficacy and safety of two LMA devices.

Detailed description

The study will investigate two types of LMA devices endowed of different constructive features. The two devices share common features as far as providing access to the stomach and reducing morbidity of the upper airway. The two device differ in regard to ease of insertion and sealing of the airway and these features are particularly important in the obese patient.

Interventions

DEVICEProSeal

Patients will be ventilated with PLMA

Patients will be ventilated with SLMA

Sponsors

Azienda Ospedaliera di Padova
CollaboratorOTHER
University of Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA class I-III * candidates to bariatric surgery

Exclusion criteria

* uncontrolled psychiatric symptomatology * known or presumed pregnancy * history of surgery on the airway or esophagus * gastroesophageal reflux

Design outcomes

Primary

MeasureTime frame
oropharyngeal leak pressureintraoperatively, up to 3 hours

Secondary

MeasureTime frame
total anesthetic and analgesic drug dosagesintraoperatively and postoperatively, up to 24 hours from end of surgery
pulse oximetry saturationintraoperatively and postoperatively, up to 24 hours from end of surgery
time to post-anesthetic discharge scoring system (PADSS) > 8in PACU up 72 hours
EKG monitoringpostoperatively up to 72 hours
satisfaction of the surgeon (ad hoc questionnaire)day 1
gastric distensionintraoperatively up to 3 hours
levels of pain and nausea (Visual Analogue Scale)postoperatively up to 24 hours
metilen's bluebefore end of surgery up to 3 hours
total dosage of analgesic and antihemetic drugsintra and postoperatively up to 24 hours
satisfaction of the patient (Iowa Satisfaction with Anesthesia Scale)day 1

Other

MeasureTime frame
insertion timeup to 10 minutes

Countries

Italy

Contacts

Primary ContactMichele Carron, MD
michele.carron@unipd.it+39 049 821 3090
Backup ContactUlderico Freo, MD
ulderico.freo@unipd.it+39 049 821 3090

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026